FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, devel... read more

Fujirebio and Sysmex Collaborate for Development and Advancement of Immunoassay

By LabMedica International staff writers
Posted on 18 Dec 2023

Image: Fujirebio and Sysmex have signed an agreement for the supply of reagent raw materials in the field of immunoassay (Photo courtesy of 123RF)

Fujirebio Holdings (Tokyo, Japan) and Sysmex Corporation (Kobe, Japan) have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The agreement is based on a basic agreement on business collaboration in the field of immunoassay signed by the two companies in October 2023.

In October 2023, Fujirebio and Sysmex entered into a basic agreement on business collaboration in the field of immunoassay, intending to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay. To promote specific initiatives, the two companies signed a Contract Development and Manufacturing Organization (CDMO) agreement in November 2023 related to dedicated reagents for the HISCL-Series automated immunoassay system, involving the development of reagents for cerebral-spinal fluid-based and blood-based testing in the field of neurodegenerative diseases, including Alzheimer’s disease.

As per the terms of the agreement, Fujirebio and Sysmex will mutually supply a wide range of reagent materials owned by each company, primarily antigens and antibodies, which are the key raw materials of immunoassay reagents. This will allow the CDMO to speed up reagent development, lower costs, and maximize the value of raw material assets while building a stable supply system to meet the global demand growth in the future and prepare for raw material procurement risk in case of an emergency. By strengthening cooperation in the area of reagent materials, Fujirebio and Sysmex will promote the mutual utilization of their high-quality reagent materials. Additionally, they will continue to work together in the future to develop new parameters and technologies.

Related Links:
Fujirebio Holdings
Sysmex Corporation